AstraZeneca PLC (AZN)
65.63
+1.37
(+2.13%)
USD |
NASDAQ |
Nov 22, 16:00
65.64
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Cash from Investing (Quarterly): -1.514B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.514B |
June 30, 2024 | -2.872B |
March 31, 2024 | -2.413B |
December 31, 2023 | -1.077B |
September 30, 2023 | -1.221B |
June 30, 2023 | -520.00M |
March 31, 2023 | -1.246B |
December 31, 2022 | -249.00M |
September 30, 2022 | -1.743B |
June 30, 2022 | -800.00M |
March 31, 2022 | -168.00M |
December 31, 2021 | -913.00M |
September 30, 2021 | -10.46B |
June 30, 2021 | -236.00M |
March 31, 2021 | 555.00M |
December 31, 2020 | 138.00M |
September 30, 2020 | -580.00M |
June 30, 2020 | 148.00M |
March 31, 2020 | 9.00M |
December 31, 2019 | 58.00M |
September 30, 2019 | 74.00M |
June 30, 2019 | -1.117B |
March 31, 2019 | 328.00M |
December 31, 2018 | 927.00M |
September 30, 2018 | -141.00M |
Date | Value |
---|---|
June 30, 2018 | -96.00M |
March 31, 2018 | 273.00M |
December 31, 2017 | -1.642B |
September 30, 2017 | -335.00M |
June 30, 2017 | -205.00M |
March 31, 2017 | -146.00M |
December 31, 2016 | 603.00M |
September 30, 2016 | -624.00M |
June 30, 2016 | -1.061B |
March 31, 2016 | -2.887B |
December 31, 2015 | -2.585B |
September 30, 2015 | -420.00M |
June 30, 2015 | -678.00M |
March 31, 2015 | -556.00M |
December 31, 2014 | -1.516B |
September 30, 2014 | -561.00M |
June 30, 2014 | -1.178B |
March 31, 2014 | -3.777B |
December 31, 2013 | -1.004B |
September 30, 2013 | -647.00M |
June 30, 2013 | -874.00M |
March 31, 2013 | -364.00M |
December 31, 2012 | -514.00M |
September 30, 2012 | -2.698B |
June 30, 2012 | 760.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-10.46B
Minimum
Sep 2021
555.00M
Maximum
Mar 2021
-1.255B
Average
-690.00M
Median
Cash from Investing (Quarterly) Benchmarks
GSK PLC | -926.64M |
Amgen Inc | -210.00M |
Johnson & Johnson | -3.128B |
Sanofi SA | -- |
Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 3.383B |
Cash from Financing (Quarterly) | -4.131B |
Free Cash Flow | 6.757B |
Free Cash Flow Per Share (Quarterly) | 0.6482 |
Free Cash Flow to Equity (Quarterly) | 4.177B |
Free Cash Flow to Firm (Quarterly) | 2.240B |
Free Cash Flow Yield | 3.29% |